Dr. Patricia Fulkerson, an authority in eosinophil biology, will analyze effects of dexpramipexole in stem cell culture system Click to View Article
Knopp Biosciences LLC, a drug discovery and development company, announced the appointment of Mark Kreston as its chief commercial officer in a release. Click to View Article
Milind Mehere keeps plenty of copies of Hillbilly Elegy, J.D. Vance’s best-selling memoir about poverty in the Rust Belt, on hand for visitors to his Midtown Manhattan office. Mehere talks about how ordinary people are shut out of opportunities to … Continued
In the introductory chapter of my recently published Sports Business book, I wrote: “Because sports engender greater emotions and engagement levels than your average business, and as we consume sport differently due to technological advancements, all players within this ecosystem (sponsors, … Continued
Knopp Biosciences was featured as both the cover story, detailing the company’s recent hypereosinophilic syndrome (HES) trial, as well as in a key editorial entitled “Dexpramipexole: a new antieosinophil drug?” in the August 2, 2018 edition of Blood. The editorial, … Continued
Milford, CT, May 22, 2018 –(PR.com)– Penna, the U.K.’s foremost talent management company, now part of the Adecco group, have entered into a new service agreement with Express KCS, focused on providing expanded services into digital ad operations and campaign … Continued
Knopp Biosciences LLC today announced the publication of a report in the journal Bloodthat a Phase 2 study of dexpramipexole in hypereosinophilic syndromes (HES) met its co-primary endpoints. A team of investigators led by Dr. Amy Klion at the National Institute … Continued
“For individual investors, getting in on asset classes like commercial real estate or litigation finance has been difficult due to barriers like lack of capital. Now the technology platform and lender YieldStreet is helping accredited investors get in on asset-based … Continued
NEW YORK–(BUSINESS WIRE)–YieldStreet, the alternative investment platform striving to change the way wealth is created, today announced strong company growth to close out Q1 2018, including: Over $317M invested by retail investors since inception in 2015. This represents a year … Continued
Trunomi, a Bermuda and London, UK-based provider of customer consent and data rights and privacy software solutions, received a $3.5m round of financing. CloudScale Capital Partners participated in the funding. The company intends to use the funds to manage the … Continued
